Prostate lung cancer adenocarcinoma. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy10

Prostate Lung Cell Line, Tumor Tumor Cells, Cultured Cardia Epithelial Cells Esophagogastric Junction Neoplastic Stem Cells Cell Line Lymph Nodes

Organisms4

Mice, Nude Mice, SCID Mice, Inbred BALB C Mice, Inbred C57BL

Diseases64

Adenocarcinoma Lung Neoplasms Carcinoma, Non-Small-Cell Lung Prostatic Neoplasms Carcinoma, Small Cell Pancreatic Neoplasms Lung Diseases Stomach Neoplasms Carcinoma, Squamous Cell Adenocarcinoma, Mucinous Esophageal Neoplasms Adenocarcinoma, Bronchiolo-Alveolar Neoplasm Metastasis Small Cell Lung Carcinoma Colonic Neoplasms Neoplasm Invasiveness Disease Progression Adenocarcinoma, Papillary Carcinoma, Pancreatic Ductal Prostatic Hyperplasia Carcinoma, Large Cell Neoplasms Barrett Esophagus Genetic Predisposition to Disease Ovarian Neoplasms Breast Neoplasms Carcinoma Lung Injury Prostatic Intraepithelial Neoplasia Neoplasm Recurrence, Local Cell Transformation, Neoplastic Precancerous Conditions Colorectal Neoplasms Endometrial Neoplasms Neoplasms, Multiple Primary Neoplasms, Hormone-Dependent Bone Neoplasms Uterine Cervical Neoplasms Rectal Neoplasms Acute Lung Injury Neovascularization, Pathologic Lymphatic Metastasis Mammary Neoplasms, Experimental Carcinoma, Adenosquamous Carcinoma, Bronchogenic Occupational Diseases Urinary Bladder Neoplasms Intestinal Neoplasms Adenoma Mesothelioma Neoplasms, Experimental Gastrointestinal Neoplasms Neoplasms, Radiation-Induced Prostatic Diseases Disease Models, Animal Carcinoma, Endometrioid Liver Neoplasms Carcinoma in Situ Metaplasia Lung Diseases, Interstitial Neoplasms, Second Primary Adenocarcinoma, Clear Cell Carcinoma, Signet Ring Cell Pleural Effusion, Malignant

Chemicals and Drugs55

Tumor Markers, Biological Prostate-Specific Antigen Antineoplastic Agents Neoplasm Proteins RNA, Messenger Receptors, Androgen Androgens DNA, Neoplasm Receptor, Epidermal Growth Factor Cisplatin Androgen Antagonists Quinazolines Antigens, Neoplasm Tumor Suppressor Protein p53 RNA, Small Interfering Antineoplastic Agents, Phytogenic Radon Deoxycytidine Paclitaxel Cancer Vaccines Taxoids Anticarcinogenic Agents Protein Kinase Inhibitors Antibodies, Monoclonal RNA, Neoplasm Carcinogens Tumor Suppressor Proteins Carcinoembryonic Antigen Proto-Oncogene Proteins Keratin-7 MicroRNAs Receptor, erbB-2 Transcription Factors Antineoplastic Agents, Hormonal DNA-Binding Proteins Antimetabolites, Antineoplastic Carboplatin ras Proteins Fluorouracil Proto-Oncogene Proteins c-akt Asbestos Ki-67 Antigen Nuclear Proteins PTEN Phosphohydrolase Etoposide DNA Primers Receptors, Estrogen Keratins Cyclooxygenase 2 Dihydrotestosterone Tosyl Compounds Membrane Proteins Radiopharmaceuticals Cadherins Vinblastine

Analytical, Diagnostic and Therapeutic Techniques and Equipment74

Neoplasm Staging Prognosis Immunohistochemistry Early Detection of Cancer Survival Rate Survival Analysis Reverse Transcriptase Polymerase Chain Reaction Antineoplastic Combined Chemotherapy Protocols Risk Factors Retrospective Studies Neoplasm Transplantation Treatment Outcome Gene Expression Profiling Case-Control Studies Prostatectomy Xenograft Model Antitumor Assays Follow-Up Studies Pneumonectomy Blotting, Western Transplantation, Heterologous Prospective Studies Kaplan-Meier Estimate Risk Sensitivity and Specificity Disease-Free Survival Combined Modality Therapy Tomography, X-Ray Computed Immunoenzyme Techniques Lung Transplantation Tissue Array Analysis Incidence Tumor Burden Oligonucleotide Array Sequence Analysis Orchiectomy Biopsy Risk Assessment Odds Ratio Neoplasm Grading Polymerase Chain Reaction Multivariate Analysis Predictive Value of Tests Cohort Studies Transurethral Resection of Prostate Biopsy, Needle Drug Screening Assays, Antitumor Registries Transfection Reproducibility of Results Chemotherapy, Adjuvant Mammary Neoplasms, Experimental SEER Program Radiotherapy Dosage Drug Administration Schedule Radiotherapy Molecular Targeted Therapy DNA Mutational Analysis Flow Cytometry Clinical Trials as Topic In Situ Hybridization, Fluorescence Logistic Models Positron-Emission Tomography Neoplasms, Experimental Bronchoscopy Gene Knockdown Techniques Proportional Hazards Models Palliative Care Models, Biological Disease Models, Animal Confidence Intervals Questionnaires Radiotherapy, Adjuvant Lung Volume Measurements Fatal Outcome Real-Time Polymerase Chain Reaction

Psychiatry and Psychology1

Phenomena and Processes39

Gene Expression Regulation, Neoplastic Cell Proliferation Apoptosis Mutation Genetic Predisposition to Disease Drug Resistance, Neoplasm Risk Sensitivity and Specificity Signal Transduction DNA Methylation Cell Division Time Factors Odds Ratio Down-Regulation Cell Survival Genes, ras Genotype Dose-Response Relationship, Drug Polymorphism, Genetic Cell Movement Up-Regulation Genes, Tumor Suppressor Promoter Regions, Genetic Cell Growth Processes Gene Expression Base Sequence Transfection Genes, p53 Cell Cycle Gene Silencing RNA Interference Loss of Heterozygosity Genes, erbB-1 Alleles Phosphorylation Phenotype Genes, Neoplasm Gene Amplification Drug Synergism

Disciplines and Occupations2

Immunohistochemistry Medical Oncology

Anthropology, Education, Sociology and Social Phenomena2

National Cancer Institute (U.S.)Quality of Life

Technology, Industry, Agriculture1

Humanities1

Quality of Life

Information Science8

Survival Rate Incidence Registries Base Sequence Molecular Sequence Data SEER Program Questionnaires Fatal Outcome

Named Groups2

Survivors European Continental Ancestry Group

Health Care31

Survival Rate Survival Analysis Risk Factors Retrospective Studies Treatment Outcome Case-Control Studies Follow-Up Studies Prospective Studies Kaplan-Meier Estimate Risk Sensitivity and Specificity Disease-Free Survival Incidence Risk Assessment Odds Ratio Multivariate Analysis Predictive Value of Tests Cohort Studies Age Factors Registries Reproducibility of Results Occupational Exposure SEER Program Clinical Trials as Topic Logistic Models National Cancer Institute (U.S.)Proportional Hazards Models Palliative Care Confidence Intervals Questionnaires Fatal Outcome

Geographicals3

United States Japan China

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Information Science Health Care Geographicals

Adenocarcinoma Prostate Lung Neoplasms Lung Carcinoma, Non-Small-Cell Lung Prostatic Neoplasms Cell Line, Tumor Carcinoma, Small Cell Gene Expression Regulation, Neoplastic Tumor Markers, Biological Neoplasm Staging Prostate-Specific Antigen Pancreatic Neoplasms Lung Diseases Stomach Neoplasms Prognosis Immunohistochemistry Carcinoma, Squamous Cell Adenocarcinoma, Mucinous Esophageal Neoplasms Adenocarcinoma, Bronchiolo-Alveolar Antineoplastic Agents Neoplasm Metastasis Mice, Nude Smoking Early Detection of Cancer Small Cell Lung Carcinoma Colonic Neoplasms Neoplasm Invasiveness Tumor Cells, Cultured Survival Rate Survival Analysis Disease Progression Neoplasm Proteins Adenocarcinoma, Papillary Reverse Transcriptase Polymerase Chain Reaction Carcinoma, Pancreatic Ductal RNA, Messenger Prostatic Hyperplasia Antineoplastic Combined Chemotherapy Protocols Risk Factors Cell Proliferation Retrospective Studies Carcinoma, Large Cell Neoplasms Receptors, Androgen Androgens Barrett Esophagus Apoptosis Neoplasm Transplantation Treatment Outcome DNA, Neoplasm Gene Expression Profiling Mutation Case-Control Studies Receptor, Epidermal Growth Factor Genetic Predisposition to Disease Prostatectomy Ovarian Neoplasms Breast Neoplasms Cisplatin Carcinoma Lung Injury Xenograft Model Antitumor Assays Follow-Up Studies Drug Resistance, Neoplasm Pneumonectomy Blotting, Western Androgen Antagonists Transplantation, Heterologous Prospective Studies Quinazolines Prostatic Intraepithelial Neoplasia Kaplan-Meier Estimate Risk Sensitivity and Specificity Cardia Antigens, Neoplasm Disease-Free Survival Combined Modality Therapy Neoplasm Recurrence, Local Cell Transformation, Neoplastic Precancerous Conditions Colorectal Neoplasms Tomography, X-Ray Computed Immunoenzyme Techniques Tumor Suppressor Protein p53 Signal Transduction Lung Transplantation Tissue Array Analysis DNA Methylation RNA, Small Interfering Endometrial Neoplasms Neoplasms, Multiple Primary Incidence Cell Division Tumor Burden Oligonucleotide Array Sequence Analysis Neoplasms, Hormone-Dependent Time Factors

No FAQ available that match "prostate lung cancer adenocarcinoma"